Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Generic medicine
Generic medicine

Fosfomycin

Fosfomycin · Anti-infectives · Other systemic antibacterials

Data statusRegistration & price fields require source verification.
12brands/products
9companies
12with current prices
Available dosage forms

Choose a form

Tap a form to filter the brand list
Advertisement · clearly labelled sponsored placement
Pakistan brand index

Available brands

Print / Save PDFAll 12 brands
ShareSend this page
12 results
Reset
BrandManufacturerStrengthFormPackReg. no.Official priceUnit price
BiofosBosch Pharmaceuticals (Pvt) Ltd.1 gInjection10's025415PKR 156.672026-07-27PKR 15.67/ vial/unit
CynfoSAMI Pharmaceuticals Pvt. Ltd.1 gPowder for IV infusion1's089069PKR 82.162026-07-23PKR 82.16/ vial/unit
DefosDe-Mont Research Laboratories (Pvt.) Ltd.3 gSachet1's084052PKR 205.562025-07-01PKR 205.56/ sachet
FaremicinEpharm Laboratories500 mgCapsule12's104329PKR 171.602025-07-01PKR 14.30/ capsule
FOFYAllmed (Pvt.) Ltd500 mgCapsule10'S052446PKR 212.662025-08-22PKR 21.27/ capsule
FosemedMedera Pharmaceuticals (Pvt) Ltd250 mgDry suspension60ml073025PKR 178.372026-07-27PKR 2.97/ mL
FosfomycinSAFE PHARMACEUTICAL (PVT) LTD1 gInjectionVial067424PKR 119.842024-07-01PKR 119.84/ vial/unit
FosfomycinSAFE PHARMACEUTICAL (PVT) LTD1 gInjectionVial067423PKR 57.042024-07-01PKR 57.04/ vial/unit
FosfomycinAdamjee Pharmaceuticals (Pvt) Ltd250 mgCapsule12's045393PKR 281.992025-07-01PKR 23.50/ capsule
FosfomycinAdamjee Pharmaceuticals (Pvt) Ltd250 mg/5 mLDry suspension60ml045394PKR 211.472025-07-01PKR 3.52/ mL
FosfomycinSAFE PHARMACEUTICAL (PVT) LTD500 mgCapsule10's067425PKR 150.102024-07-01PKR 15.01/ capsule
TrifocinTRISON RESEARCH LABORATORIES PRIVATE LIMITED250 mgSuspension60ml063304PKR 166.192026-07-29PKR 2.77/ mL
Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.